News
Information
Electronic delivery
As part of the reshaping of its IT-system, the Austrian Federal Office for Safety in Health Care plans to issue all decisions and notifications electronically in the near future, the envisaged date being May 2012.
Safety-News
Ukrain (extract of greater celandine [Chelidonium majus])
For reasons of patient protection, Ukrain, a product promoted, illegally marketed, and used as an anticancer drug, must not be manufactured or offered for sale in Austria.
AGES PharmMed
New Slot-alert mailing list for the slot-allocation for DCPs
with Austria as Reference Member State.
New Web Portal
For the Submission of Applications or Notifications
The Federal Office for Safety in Health Care (Bundesamt für Sicherheit im Gesundheitswesen, BASG) hereby informs you that, as of 4 July 2011, applications and notifications in accordance with the Austrian Medicinal Products Import Act (Arzneiwareneinfuhrgesetz, AWEG), Federal Gazette I No. 79/2010, are to be submitted electronically via a web portal.
Earthquake in Japan
Monitoring of products for the possibility of radioactivity
The European Competent Authorities are working with its European and international regulatory partners to monitor and evaluate the possible risk of radioactive contamination of medicines manufactured in Japan following the radiation leak from the Fukushima Daiichi nuclear power plant.